These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 35997100)

  • 1. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
    Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
    Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
    Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
    Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.
    Gote V; Nookala AR; Bolla PK; Pal D
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotheranostics for Diagnosis and Treatment of Breast Cancer.
    Patel P; Kumar K; Jain VK; Popli H; Yadav AK; Jain K
    Curr Pharm Des; 2023; 29(10):732-747. PubMed ID: 36999427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanosoldiers: A promising strategy to combat triple negative breast cancer.
    Pawar A; Prabhu P
    Biomed Pharmacother; 2019 Feb; 110():319-341. PubMed ID: 30529766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-based active targeting strategies for cancer theranostics.
    Bandyopadhyay A; Das T; Nandy S; Sahib S; Preetam S; Gopalakrishnan AV; Dey A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3417-3441. PubMed ID: 37466702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in nanotheranostics for triple negative breast cancer treatment.
    Thakur V; Kutty RV
    J Exp Clin Cancer Res; 2019 Oct; 38(1):430. PubMed ID: 31661003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics.
    Rahimkhoei V; Alzaidy AH; Abed MJ; Rashki S; Salavati-Niasari M
    Adv Colloid Interface Sci; 2024 Jul; 329():103204. PubMed ID: 38797070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
    Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric nanomaterials-based theranostic platforms for triple-negative breast cancer (TNBC) treatment.
    Reddy Baddam S; Ganta S; Nalla S; Banoth C; Vudari B; Akkiraju PC; Srinivas E; Tade RS
    Int J Pharm; 2024 Jul; 660():124346. PubMed ID: 38889853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch-folic acid conjugates stabilized theranostic nanoparticles for cancer therapy.
    Wang C; Wang Q; Wang H; Li Z; Chen J; Zhang Z; Zeng H; Yu X; Yang X; Yang X; Li Z
    J Control Release; 2023 Jan; 353():391-410. PubMed ID: 36473606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered Polymer-Based Nanomaterials for Diagnostic, Therapeutic and Theranostic Applications.
    Parisi OI; Scrivano L; Sinicropi MS; Picci N; Puoci F
    Mini Rev Med Chem; 2016; 16(9):754-61. PubMed ID: 26156541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.